Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 7;16(1):655.
doi: 10.4102/jphia.v16i1.655. eCollection 2025.

Bacteraemia in a Nigerian hospital: Implementing antimicrobial resistance surveillance

Adewale A Amupitan  1   2 , Adeyemi T Adeyemo  1   2 , Adefunke O Amupitan  3 , Temitope O Obadare  1   2 , Aaron O Aboderin  1   2
Affiliations

Bacteraemia in a Nigerian hospital: Implementing antimicrobial resistance surveillance

Adewale A Amupitan et al. J Public Health Afr. .

Abstract

Background: Surveillance of drug-resistant infections is crucial for antimicrobial resistance (AMR) control. Implementing surveillance in low- and middle-income countries (LMICs) is challenging.

Aim: To investigate bacteraemia and describe AMR surveillance.

Setting: Tertiary healthcare facility.

Methods: Case finding was by WHO Global AMR and Use Surveillance System (GLASS). Blood samples were processed between May 2017 and June 2018, using BACTEC blood culture system. Bacterial identification, antibiotic susceptibility testing and detection of AMR genes followed standard protocols.

Results: Aerobic blood cultures were conducted in a third of clinical sepsis cases (n = 601/1851), of which 114 (19.0%) were true positives, with a 2.2% contamination rate. Pathogens recovered included six priority blood pathogens reportable to WHO GLASS. Sixteen (30.2%) of 53 Gram-negative isolates were extended-spectrum beta-lactamase producers, predominantly harbouring bla CTX-M, three (5.7%) were AmpC beta-lactamase producers, and 20 (37.7%) were carbapenem-resistant, predominantly harbouring bla KPC. Twenty-nine (50.9%) of 57 Staphylococcus aureus isolates were methicillin-resistant; 17 (58.6%) of these harboured mecA genes. Hospital-acquired infection (odds ratio [OR] = 0.3, 95% confidence interval [CI]=0.1-0.7, p = 0.004) was identified as a predisposing factor for the development of multidrug-resistant (MDR) bacteraemia. Bacteraemia with MDR organisms was significantly associated with mortality (OR = 3.8, 95% CI = 1.6-9.1, p = 0.001).

Conclusion: A wide variety of bacteria are responsible for bacteraemia in our setting, with more than half being multidrug-resistant. Bacteraemia with multidrug-resistant organisms was significantly associated with mortality, hence, the need for this AMR surveillance initiative.

Contribution: Implementing healthcare facility-based surveillance of AMR in LMICs is achievable despite limited microbiological laboratory capacity.

Keywords: GLASS; Nigeria; antimicrobial-resistance; bacteraemia; healthcare-facility; implementation; multidrug resistance; surveillance.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.

References

    1. Lim C, Ashley EA, Hamers RL, et al. . Surveillance strategies using routine microbiology for antimicrobial resistance in low- and middle-income countries. Clin Microbiol Infect. 2021;27(10):1391–1399. 10.1016/j.cmi.2021.05.037 - DOI - PMC - PubMed
    1. Okeke IN, Feasey N, Parkhill J, et al. . Leapfrogging laboratories: The promise and pitfalls of high-tech solutions for antimicrobial resistance surveillance in low-income settings. BMJ Glob Health. 2020;5(12):1–9. 10.1136/bmjgh-2020-003622 - DOI - PMC - PubMed
    1. Musicha P, Cornick JE, Bar-Zeev N, et al. . Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998–2016): A surveillance study. Lancet Infect Dis. 2017;17(10):1042–1052. 10.1016/S1473-3099(17)30394-8 - DOI - PMC - PubMed
    1. Murray CJ, Ikuta KS, Sharara F, et al. . Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet. 2022;399(10325):629–655. 10.1016/S0140-6736(21)02724-0 - DOI - PMC - PubMed
    1. World Health Organization . Global antimicrobial resistance surveillance system: manual for early implementation. Geneva: WHO Press; 2015; 1–36.

LinkOut - more resources